Core Viewpoint - Nengte Technology (002102.SZ) reported a significant decrease in revenue for the first half of 2025, while net profit saw a substantial increase, indicating a shift in profitability dynamics despite lower sales [1] Financial Performance - The company's operating revenue for the first half of 2025 was 5.229 billion yuan, a year-on-year decrease of 16.09% [1] - Net profit attributable to shareholders was 339 million yuan, reflecting a year-on-year increase of 496.36% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 411 million yuan, showing a remarkable year-on-year growth of 759.36% [1] - Basic earnings per share were reported at 0.1288 yuan [1] Business Segment Performance - The wholly-owned subsidiary, Nengte Technology Co., Ltd., maintained good operational performance in the vitamin E and pharmaceutical intermediates business, contributing approximately 447 million yuan in profit, which marked a significant increase compared to the same period last year [1]
能特科技(002102.SZ)发布上半年业绩,归母净利润3.39亿元,增长496.36%